Literature DB >> 30054724

Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis.

Amit Kishore1,2, Britt-Sabina Petersen1, Marcel Nutsua1, Joachim Müller-Quernheim3, Andre Franke1, Annegret Fischer1, Stefan Schreiber4,5, Martin Petrek6.   

Abstract

Genome-wide and candidate gene studies for pulmonary sarcoidosis have highlighted several candidate variants among different populations. However, the genetic basis of functional rare variants in sarcoidosis still needs to be explored. To identify functional rare variants in sarcoidosis, we sequenced exomes of 22 sarcoidosis cases from six families. Variants were prioritized using linkage and high-penetrance approaches, and filtered to identify novel and rare variants. Functional networking and pathway analysis of identified variants was performed using gene ontology based gene-phenotype, gene-gene, and protein-protein interactions. The linkage (n = 1007-7640) and high-penetrance (n = 11,432) prioritized variants were filtered to select variants with (a) reported allele frequency < 5% in databases (1.2-3.4%) or (b) novel (0.7-2.3%). Further selection based on functional properties and validation revealed a panel of 40 functional rare variants (33 from linkage region, 6 highly penetrant and 1 shared by both approaches). Functional network analysis implicated these gene variants in immune responses, such as regulation of pro-inflammatory cytokines including production of IFN-γ and anti-inflammatory cytokine IL-10, leukocyte proliferation, bacterial defence, and vesicle-mediated transport. The KEGG pathway analysis indicated inflammatory bowel disease as most relevant. This study highlights the subsets of functional rare gene variants involved in pulmonary sarcoidosis, such as, regulations of calcium ions, G-protein-coupled receptor, and immune system including retinoic acid binding. The implicated mechanisms in etiopathogenesis of familial sarcoidosis thus include Wnt signalling, inflammation mediated by chemokine and cytokine signalling and cadherin signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30054724     DOI: 10.1007/s00439-018-1915-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  54 in total

1.  Pooled association tests for rare variants in exon-resequencing studies.

Authors:  Alkes L Price; Gregory V Kryukov; Paul I W de Bakker; Shaun M Purcell; Jeff Staples; Lee-Jen Wei; Shamil R Sunyaev
Journal:  Am J Hum Genet       Date:  2010-05-13       Impact factor: 11.025

2.  Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR.

Authors:  Hui Yang; Kai Wang
Journal:  Nat Protoc       Date:  2015-09-17       Impact factor: 13.491

3.  Phenolyzer: phenotype-based prioritization of candidate genes for human diseases.

Authors:  Hui Yang; Peter N Robinson; Kai Wang
Journal:  Nat Methods       Date:  2015-07-20       Impact factor: 28.547

4.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

Review 5.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

6.  Genome-wide association study identifies variants at the IL18-BCO2 locus associated with interleukin-18 levels.

Authors:  Meian He; Marilyn C Cornelis; Peter Kraft; Rob M van Dam; Qi Sun; Cathy C Laurie; Daniel B Mirel; Daniel I Chasman; Paul M Ridker; David J Hunter; Frank B Hu; Lu Qi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-11       Impact factor: 8.311

7.  Ketoconazole for the treatment of refractory hypercalcemic sarcoidosis.

Authors:  M Conron; H L Beynon
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2000-10       Impact factor: 0.670

Review 8.  Calcium and vitamin D in sarcoidosis: how to assess and manage.

Authors:  Robert R Burke; Benjamin A Rybicki; D Sudhaker Rao
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

9.  Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis.

Authors:  Dashant Kavathia; John D Buckley; Dhanwada Rao; Benjamin Rybicki; Robert Burke
Journal:  Respir Med       Date:  2010-01-13       Impact factor: 3.415

Review 10.  The impact of rare and low-frequency genetic variants in common disease.

Authors:  Lorenzo Bomba; Klaudia Walter; Nicole Soranzo
Journal:  Genome Biol       Date:  2017-04-27       Impact factor: 13.583

View more
  4 in total

Review 1.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

2.  An amelanotic choroidal melanoma arising in a young man with tattoo-associated sarcoidosis.

Authors:  Sean T Berkowitz; Anderson L Brock; David A Reichstein
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-07

3.  Exome Sequencing Identifies Susceptibility Loci for Sarcoidosis Prognosis.

Authors:  Elisa Lahtela; Matti Kankainen; Juha Sinisalo; Olof Selroos; Marja-Liisa Lokki
Journal:  Front Immunol       Date:  2019-12-24       Impact factor: 7.561

4.  Whole genome sequencing identifies variants associated with sarcoidosis in a family with a high prevalence of sarcoidosis.

Authors:  Daan Fritz; Bart Ferwerda; Matthijs C Brouwer; Diederik van de Beek
Journal:  Clin Rheumatol       Date:  2021-04-27       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.